FIELD: medicine.
SUBSTANCE: invention belongs to medicine, notably to laboratory method of diagnostics. Principle of the method is isolation and identification of pathogenic and opportunistic microorganisms from biopsic material of common bile duct and assessment of antilysozim activity of isolated microorganisms. Antilysozim activity index 5.5±0.5 mcg/ml confirms acute purulent cholangitis diagnosis, 3.7±0.6 mcg/ml characterises acute recurrent purulent cholangitis, while index 1.1±0.4 mcg/ml supposes chronic purulent cholangitis.
EFFECT: method allows differential diagnostics of purulent cholangitis.
2 ex, 2 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTION OF POSTOPERATIVE PYOINFLAMMATORY COMPLICATIONS DEVELOPMENT IN PATIENTS WITH PURULENT CHOLANGITIS | 2009 |
|
RU2399054C1 |
METHOD OF PURULENT CHOLANGITIS TREATMENT | 2008 |
|
RU2404825C2 |
METHOD TO PREDICT CHOLANGITIS | 1995 |
|
RU2109283C1 |
METHOD OF MODELLING PURULENT OBSTRUCTIVE CHOLANGITIS | 2010 |
|
RU2434307C1 |
METHOD OF DIAGNOSING INFLAMMATION OF BILIARY DUCTS | 1997 |
|
RU2125729C1 |
DIAGNOSTIC TECHNIQUE FOR PURULENT CHOLANGITIS | 2011 |
|
RU2466409C1 |
METHOD OF CHOLEDOCHO- AND HEPATICOJEJUNOSTOMY | 1996 |
|
RU2122361C1 |
METHOD OF TREATING PURULENT CHOLANGITIS | 2011 |
|
RU2470600C1 |
METHOD FOR TREATING THE CASES OF PURULENT CHOLANGITIS | 1991 |
|
RU2040913C1 |
METHOD OF MICROORGANISM ANALYSIS FOR PRODUCING INHIBITORS OF ANTIMICROBIAL THROMBOCYTE PROTEIN (β-LYSINE) | 2007 |
|
RU2351654C2 |
Authors
Dates
2010-06-20—Published
2009-01-22—Filed